At the 2025 Veeva Commercial Summit Europe, industry professionals gathered to discuss AI’s role in pharma and the life sciences industry. Executives expressed excitement for AI’s potential to drive efficiency, but stressed the importance of finding the best use cases and addressing current pitfalls to ensure trust and accuracy.
A new form of AI, agentic AI, has caught the attention of the pharma industry for its ability to autonomously carry out tasks. Bayer’s digital capability lead, Stefan Schmidt, predicts that agentic AI will reduce manual workload for administrative tasks, but emphasizes the need for trust and gradual adoption.
To maximize the benefits of agentic AI, it must be deeply embedded into daily workflows in the life sciences industry. Veeva’s European commercial strategy VP, Philipp Luik, highlights the importance of integrating AI comprehensively to achieve productivity gains and keep up with the technology’s rapid evolution.
Quality data is crucial for the success of AI strategies in the life sciences sector. Experts at the summit emphasized the importance of high-quality, accurate, complete, reliable, and compliant data to generate the best results from AI models. Ensuring compliance and protection within systems is also essential.
While interest in AI is growing, some in the industry remain sceptical about its benefits and use cases. Challenges such as unfocused pilots and complex AI models can lead to poor adoption and limited value. Moderna, however, has embraced AI as a “digital-first company,” easing the transition for its staff and maximizing the technology’s potential. Moderna is prioritizing AI training for all employees, establishing an AI academy for full-day courses on the technology. Veeva Systems’ Karl Goossens agrees on the importance of explaining AI benefits to staff. Trust in AI is crucial for its full potential, according to Veeva Systems’ Chris Moore and Moderna’s Benagh. Reviewers must fully trust AI capabilities for successful implementation, especially in the pharma industry. The Veeva Commercial Summit emphasizes responsible AI usage and quality data to enhance operational efficiency in the life sciences sector by 2025.
Read more at Yahoo Finance: future-proofed AI set to bolster commercial pharma operations